sunny.png
Saturday June 12th, 2021 7:49PM

New era begins at Merck as pandemic cuts Q1 sales, profit

By The Associated Press
Related Articles
  Contact Editor

Merck is entering a new era, with sweeping changes across its executive suite and the spinoff off its women's health and other businesses, a bid to enable both resulting companies to grow faster.

The massive management makeover, mostly triggered by longtime Chief Executive Ken Frazier's upcoming retirement, occurs as the drugmaker says hits to sales of many of its medicines amid lockdowns and other impacts from the global coronavirus pandemic will lessen and sales will rise over the rest of the year.

Frazier, who has run Merck & Co. since January 2011, oversaw a quadrupling of revenue and Merck's emergence as a powerhouse in cancer drugs over the decade.

Now 66 and the only Black CEO of a major drugmaker, Frazier will retire on June 30, causing a domino effect of job changes. He'll be succeeded by Chief Financial Officer Rob Davis, who will be replaced by company treasurer Caroline Litchfield. Her replacement hasn’t been named yet.

Michael Nally, head of marketing for Merck’s huge prescription drug business and a candidate to replace Frazier, departed last month. The chief commercial officer for that business, Frank Clyburn, will become its president and lead both commercial strategy and marketing.

And in January, Dr. Dean Li became head of Merck’s highly regarded research labs, taking over for now-retired Roger Perlmutter.

On Thursday, Merck reported its first-quarter profit dipped 1% as people continued to put off doctor and hospital visits early this year due to the COVID-19 pandemic, and it spent more on research and production.

“Results were disappointing relative to expectations," Edward Jones analyst Ashtyn Edwards wrote to investors, noting lower rates of new diagnoses, such as for cancer, “were greater than expected during the first quarter.”

Even though Merck maintained its 2021 profit forecast, its shares plunged more than 5%.

The drugmaker said it's focusing its efforts on fighting the pandemic on two fronts: testing of its experimental COVID-19 treatment molnupiravir with partner Ridgeback Biotherapeutics, and helping to manufacture Johnson & Johnson's COVID-19 vaccine under a recent deal. The J&J partnership follows the failure of two experimental vaccines that Merck dropped after early results showed they weren't very effective.

Merck plans to soon begin late-stage testing of molnupiravir, a pill meant for treating outpatients to prevent hospitalizations. The company, based in Kenilworth, New Jersey, also is evaluating the drug's potential for preventing infection in people recently exposed to the COVID-19 virus.

The maker of cancer blockbuster Keytruda and Januvia diabetes pills said net income declined to $3.18 billion, or $1.25 per share, from $3.22 billion, or $1.26 per share, a year earlier.

Adjusted earnings came to $3.56 billion, or $1.40 per share, far below the $1.63 Wall Street was expecting.

Revenue totaled $12.08 billion, up just a tad from $12.06 billion last year.

Frazier told analysts on a conference call to discuss the results that he’s confident in Merck’s future and new leadership.

But in afternoon training, shares were down $4.01, or 5.2%, at $73.08.

Merck’s prescription drug sales were hurt by generic competition to several drugs, and the pandemic reduced sales of doctor-administered drugs and other medicines used in hospitals, a key business for Merck. Sales of Merck’s vaccines for children and adults fell as the country focused on a massive COVID-19 vaccination campaign under the new Biden administration.

Prescription drug sales were flat at $10.68 billion, led by cancer immunotherapy Keytruda, which hauled in $3.9 billion — nearly one-third of total revenue. Januvia and combo drug Janumet for Type 2 diabetes brought in a total of $1.3 billion.

Veterinary medicine sales jumped 17% to $1.42 billion, mainly driven by higher sales of products for pets.

During the quarter, Merck started a partnership with Gilead Sciences developing long-acting HIV treatments that combine one drug from each company. And on April 1, Merck completed the acquisition of Pandion Therapeutics, a developer of therapies for autoimmune disorders, an area where Merck hopes to expand.

In addition, during the quarter the U.S. Food and Drug Administration approved new heart failure drug Verquvo and began reviewing applications to approve three experimental drugs, for chronic cough, for a rare condition associated with kidney cancer and for an improved pneumococcal vaccine.

Merck expects adjusted earnings per share for 2021 of $6.48 to $6.68 and revenue of $51.8 billion and $53.8 billion; both are unchanged from its January forecast.

Merck plans on June 2 to complete the spinoff of its Organon women’s health business, which will now also include off-patent former blockbusters like respiratory drugs Singulair and Nasonex, plus Merck’s unit that makes biosimilars, or near-copies of pricey biologic drugs.

If the spinoff happens by then, Merck plans to update its financial forecasts.

____

Follow Linda A. Johnson at https://twitter.com/LindaJ_onPharma

  • Associated Categories: Associated Press (AP), AP Health, AP Business, AP Business - Corporate News, AP Health - Women's health, AP Business - Industries, AP Business - Health Care
© Copyright 2021 AccessWDUN.com
All rights reserved. This material may not be published, broadcast, rewritten, or redistributed without permission.
An unusual coalition as Supreme Court rules for immigrant
An unusual coalition of Supreme Court justices has joined to rule in favor of an immigrant fighting deportation
11:33AM ( 6 minutes ago )
New era begins at Merck as pandemic cuts Q1 sales, profit
Merck is entering a new era, with sweeping changes across its executive suite and the spinoff off its women’s health and other businesses, a bid to enable both resulting companies to grow faster
11:14AM ( 25 minutes ago )
Alarm grows in Africa as it watches India's COVID-19 crisis
Africa's top public health official says the continent is “watching with total disbelief” as India struggles with a devastating resurgence in COVID-19 cases
11:10AM ( 29 minutes ago )
Associated Press (AP)
Is it safe to go to big sporting events during the pandemic?
Experts are still cautioning against attending big sporting events during the pandemic, but say there are ways to make it safer if you go
10:31AM ( 1 hour ago )
The Latest: NYC mayor expects city to reopen by July 1
New York City Mayor Bill de Blasio expects the city to “fully reopen” by July 1, with the lifting of the city’s COVID-19 restrictions
10:29AM ( 1 hour ago )
FDA revives federal effort to ban menthol cigarettes
U.S. health regulators are pledging again to try to ban menthol cigarettes
10:18AM ( 1 hour ago )
AP Health
American coach Marsch to take over at German team Leipzig
American coach Jesse Marsch will take over at German soccer team Leipzig next season
10:50AM ( 49 minutes ago )
Daimler Truck, Volvo to make fuel cells in Europe from 2025
Daimler's AG's truck business and Volvo Group are getting ready to make climate-friendly hydrogen fuel cells for long-haul trucks together
10:49AM ( 51 minutes ago )
US economy accelerated at a robust 6.4% rate last quarter
The U.S. economy grew at a brisk 6.4% annual rate last quarter — a show of strength fueled by government aid and declining viral cases that could drive further gains as the nation rebounds with unusual speed from the pandemic recession
9:56AM ( 1 hour ago )
AP Business
Gone Fission: Controversial nuke plant near NYC shuts down
Indian Point north of New York City will permanently stop producing nuclear power Friday
8:11AM ( 3 hours ago )
Widespread infections early in the year weigh on Merck Q1
Drugmaker Merck’s first-quarter profit dipped 1%, due to flat sales as the COVID-19 pandemic continued to limit doctor and hospital visits, along with higher spending on research and medicine production
7:39AM ( 4 hours ago )
McDonald's sales soar on strong US demand
As America emerges from the pandemic, it’s heading to McDonald’s
7:06AM ( 4 hours ago )
AP Business - Corporate News
Arizona governor signs abortion ban for genetic issues
Arizona Gov. Doug Ducey has signed a sweeping anti-abortion bill banning the procedure if the woman seeks it solely because a fetus has a genetic abnormality such as Down syndrome
8:04PM ( 1 day ago )
The Latest: India sets another daily record of 346,000 cases
For the third day in a row, India set a global daily record with 346,786 coronavirus cases
10:52AM ( 5 days ago )
The Latest: NYC offers walk-up vaccinations for all ages
Appointments are no longer necessary at any of the coronavirus vaccination sites run by New York City
9:10AM ( 5 days ago )
AP Health - Women's health
Top court: Germany must set clear post-2030 climate goals
Germany’s top court has ruled that the government has to set clear goals for reducing greenhouse gas emissions after 2030, arguing that current legislation doesn’t go far enough in curbing climate change
5:54AM ( 5 hours ago )
The Latest: S. Korea fast-tracking Olympians for vaccination
South Korea has begun administering fast-track COVID-19 vaccines to athletes, coaches and others expected to attend the Tokyo Olympics
3:56AM ( 7 hours ago )
The Latest: Nepal starts 15-day lockdown as COVID-19 spikes
Offices were closed, markets were shuttered and vehicles were forced off the streets in Nepal’s capital as authorities imposed a 15-day lockdown because of spiking COVID-19 cases
3:19AM ( 8 hours ago )
AP Business - Industries
The Latest: Biden stresses the need for global cooperation
President Joe Biden is stressing the need for global engagement and cooperation on everything from the COVID-19 pandemic to climate change
10:03PM ( 13 hours ago )
The Latest: Biden says he intends to raise taxes on richest
President Joe Biden says he’s “not looking to punish anybody” but does plan to raise taxes on the wealthiest Americans
9:58PM ( 13 hours ago )
The Latest: Biden makes direct appeal to blue-collar workers
President Joe Biden is making a direct appeal to blue-collar workers as he pitches his massive spending package during his joint address to Congress
9:41PM ( 13 hours ago )
AP Business - Health Care
Alarm grows in Africa as it watches India's COVID-19 crisis
Africa's top public health official says the continent is “watching with total disbelief” as India struggles with a devastating resurgence in COVID-19 cases
11:10AM ( 29 minutes ago )
Feds raid Giuliani's home, office, escalating criminal probe
Former President Donald Trump is defending Rudy Giuliani, his longtime personal lawyer, after federal investigators executed search warrants at Giuliani’s Manhattan residence and office
11:05AM ( 34 minutes ago )
Court: Germany must share climate burden between young, old
Germany’s top court has ruled that the government has to set clear goals for reducing greenhouse gas emissions after 2030, arguing that current law risks placing too much of a burden for curbing climate change on younger generations
11:05AM ( 35 minutes ago )
McDonald's comes roaring back as restrictions ease
The bounce back for McDonald’s as restrictions were lifted across the U.S. was so strong in the first quarter that the company surpassed sales during the same period even in 2019, long before the pandemic broadsided the country
11:03AM ( 36 minutes ago )
US recovery from pandemic recession is showing momentum
The U.S. economy grew at a brisk 6.4% annual rate last quarter — a show of strength fueled by government aid and declining viral cases that could drive further gains as the nation rebounds with unusual speed from the pandemic recession
10:56AM ( 44 minutes ago )